Josh Shimmer
Analyst, Cantor
Replay available
Palvella Therapeutics, Inc. (PVLA) Q3 2025 Earnings Call
Palvella Therapeutics, Inc. (NASDAQ: PVLA) Q3 2025 earnings conference call, held 2025-11-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Jeff Martini
Chief Scientific Officer
Catherine Novak
Analyst, Jones
TD Cowan
Analyst, TD Cowen
Bo Hanway
Investor Relations
Wes Coffin
Founder and Chief Executive Officer
Trevor Allred
Analyst, Oppenheimer
Matt Korenberg
Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Palvella Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.195 Good day and thank you for standing by. Welcome to Palbella's third quarter 2025 financial 00:00:04.195 -- 00:00:06.518 results and corporate update conference call. 00:00:06.518 -- 00:00:09.221 At this time, all participants are in listen-only mode. 00:00:09.221 -- 00:00:12.364 After the speaker's presentation, there'll be a question and answer session. 00:00:12.364 -- 00:00:15.708 To ask a question during the session, you'll need to press star one one on your telephone. 00:00:15.708 -- 00:00:18.591 You will then hear an automated message advising your hand is raised. 00:00:18.591 -- 00:00:21.574 To withdraw your question, please press star one one again. 00:00:21.574 -- 00:00:24.197 Please be advised, today's conference is being recorded. 00:00:24.197 -- 00:00:26.099 I would like to hand the conference over to your speaker today. 00:00:26.099 -- 00:00:29.022 Bo Hanway, please go ahead. 00:00:29.022 -- 00:00:33.224 Thank you, Operator. Good morning, and thank you for joining the Palvela Therapeutics 00:00:33.224 -- 00:00:38.151 third quarter 2025 financial results and corporate update call. 00:00:38.151 -- 00:00:41.836 As a reminder, our press release detailing today's announcements can be found in the 00:00:41.836 -- 00:00:46.159 investor section of our website at www.palvelatx.com. 00:00:47.724 -- 00:00:51.509 On today's call, you will first hear from Wes Coffin, our founder and chief executive 00:00:51.509 -- 00:00:56.515 officer, followed by Dr. Jeff Martini, our chief scientific officer, and Matt 00:00:56.515 -- 00:01:01.148 Korenberg, our chief financial officer. Wes will return for closing remarks before we 00:01:01.148 -- 00:01:03.930 open the line for Q&A. 00:01:04.874 -- 00:01:08.860 Before we begin, please note that tod...